Disopyramide in Ventricular Tachycardia

Administration of disopyramide phosphate i.v. in two doses, 30 min apart, to a patient with ventricular tachycardia was accompanied by no, or only slight, changes in systemic arterial pressure, cardiac output, stroke work, and pulmonary artery diastolic pressure

Johan Hulting; Gunnar Rosenhamer


Scholarcy highlights

Need more features? Save interactive summary cards to your Scholarcy Library.